|
|||||
|
|
Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor |
|
| Authors: | Jessica M. Bright BASc Holly J. Carlisle PhD Alyssa M. A. Toda PhD Molly Murphy BS Tyler P. Molitor PhD Paul Wren PhD Kristin M. Andruska MD PhD Enchi Liu PhD Carrolee Barlow MD PhD |
| Affiliation: | 1. ESCAPE Bio, Inc., South San Francisco, California, USA;2. Parkinson's Institute and Clinical Center, Mountain View, California, USA;3. ESCAPE Bio, Inc., South San Francisco, California, USA Parkinson's Institute and Clinical Center, Mountain View, California, USA |
| Abstract: | |
| Keywords: | pharmacodynamic biomarker Parkinson's disease G2019S LRRK2 peripheral blood mononuclear cells |